Quintian Pharma
Quintian Pharma is a privately held, Malta-based micro-company founded in 2015 that provides pharmaceutical industry services and assistance to clients pursuing EU regulatory compliance for new products.
- Company typePrivate
- Founded2015
- HeadquartersSliema, Malta
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Quintian Pharma does
Quintian Pharma is a privately held, micro-cap company founded in 2015 and headquartered in Sliema, Malta. According to its firmographic profile, the company is devoted to providing pharmaceutical industry services and assistance while adhering to all EU directives on new products. Its stated functional orientation is regulatory-aligned pharma services, suggesting a focus on supporting pharmaceutical companies, manufacturers, or distributors with EU market-entry, product compliance, or regulatory affairs work.
The input data does not disclose specific products, a service catalog, an underlying technology platform, pricing model, customer segments, or named clients. The company's website (quintianpharma.com) returned only a loading/verification interstitial rather than substantive company content during data collection, so core operational details — including whether Quintian Pharma operates as a consulting firm, distribution intermediary, regulatory affairs advisor, or contract service provider — cannot be confirmed from the inputs. No management team, certifications, partnerships, patents, or awards were disclosed.
With a stated headcount of 1-10 employees and no disclosed funding, ownership structure beyond "private," or operating geographies beyond Malta, Quintian Pharma presents as a small, privately held services entity whose commercial footprint, financial trajectory, and strategic momentum cannot be assessed from the data on hand. The principal inference opportunity — that the EU-compliance framing implies regulatory affairs or pharmacovigilance consulting targeted at EU-bound pharma manufacturers — is consistent with the company description but remains unverified by the source material.
Quintian Pharma firmographics
Firmographics- Name
- Quintian Pharma
- Website
- https://quintianpharma.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Quintian Pharma is a privately held, Malta-based micro-company founded in 2015 that provides pharmaceutical industry services and assistance to clients pursuing EU regulatory compliance for new products.
- Ownership category
- akta.pro rank
Quintian Pharma industry classification
Industry- Product category
- Pharmaceutical Services
- NAICS
- Management Consulting Services (54161), Other Management Consulting Services (541618)
- SIC
- Services-Management Consulting Services (8742)
- akta.pro primary industry
- Pharmacovigilance Quality & Compliance (PV audits, QPPV support, PSMF) (HLAGAKAH)
Keywords
Where Quintian Pharma is headquartered
LocationHeadquarters
- HQ city
- Sliema
- HQ country
- Malta
- HQ region
- Europe
Markets served
Quintian Pharma business model
Business model- GTM type
- B2B
- Offering type
- Services
Quintian Pharma product offering
Product offeringCore offering
Quintian Pharma provides services and assistance to the pharmaceutical industry, with a focus on supporting new product development in compliance with EU directives. The firm operates as a small private entity based in Sliema, Malta, offering industry-specific support services to pharmaceutical clients.
Differentiator
Problem solved
Functional benefit
Companies that use Quintian Pharma
Customer profileIdeal customer profiles1 record
Quintian Pharma technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Quintian Pharma partnerships and signals
Strategic signalRecent moves1 record
Quintian Pharma competitors and assessment
Company assessmentDirect peers
- DMA Pharma (formerly NDA Group): DMA Pharma (formerly NDA Group) provides EU regulatory strategy, HTA, and scientific advice to pharma — direct comparability on EU regulatory consulting for new products.
- Voisin Consulting Life Sciences: Voisin provides regulatory affairs, clinical development, and pharmacovigilance consulting to pharma clients in Europe — a direct comparability match on EU regulatory service offerings.
- PharmaLex: PharmaLex (merged with CPHI) is a regulatory affairs, pharmacovigilance, and quality/compliance consultancy serving pharma and biotech across the EU — directly comparable to Quintian's stated EU regulatory services focus.
- ProPharma Group: ProPharma Group specializes in regulatory compliance, pharmacovigilance, and quality consulting for pharma — directly comparable niche regulatory services player.
- BlueReg Consulting: BlueReg is a European-headquartered regulatory affairs consultancy offering MAAs, scientific advice, and lifecycle management — closely comparable to Quintian's EU regulatory focus.
Broad incumbents
- ICON plc: ICON is a large global CRO with substantial EU regulatory affairs capabilities as part of a broader clinical/research portfolio — comparable on regulatory services but far broader in scope.
- Parexel International: Parexel is a global CRO offering EU regulatory strategy, MAAs, and PV services alongside clinical operations — overlaps with Quintian's stated scope but at global scale.
- Charles River Laboratories: Charles River offers regulatory consulting and CDMO services in Europe as part of a broader life sciences portfolio — comparable regulatory advisory dimension within a much larger franchise.
Emerging players
- Inspired Pharma Training: Inspired Pharma focuses on regulatory affairs and GxP training/consulting for pharma, including EU directives — adjacent to Quintian's stated scope at smaller scale.
Others
- Covington & Burling (Life Sciences practice): Covington's life sciences practice includes EU regulatory counsel and EMA-facing work — adjacent as a legal/regulatory service provider to pharma, though structured as a law firm.
Market position
Strengths3 records
Weaknesses4 records
Competitive moat1 record
Key risks5 records
Key highlights4 records
Customer concentration
Quintian Pharma social profiles
Digital presenceQuintian Pharma financial estimates
Financial estimateRevenue estimate
Valuation estimate
Quintian Pharma leadership team
Management profileNumber of profiles
Quintian Pharma funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Quintian Pharma M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Quintian Pharma
What does Quintian Pharma do?
Quintian Pharma provides services and assistance to the pharmaceutical industry, with a focus on supporting new product development in compliance with EU directives. The firm operates as a small private entity based in Sliema, Malta, offering industry-specific support services to pharmaceutical clients.
When was Quintian Pharma founded?
Quintian Pharma was founded in 2015. It employs 1 to 10 people.
Where is Quintian Pharma based?
Quintian Pharma is headquartered in Sliema, Malta, in the Europe region.
Who are Quintian Pharma's main competitors?
Direct peers on record are DMA Pharma (formerly NDA Group), Voisin Consulting Life Sciences, PharmaLex, ProPharma Group and BlueReg Consulting. Broad incumbents are ICON plc, Parexel International and Charles River Laboratories. Inspired Pharma Training is listed as an emerging player. Covington & Burling (Life Sciences practice) is listed as an others.
Does Quintian Pharma have an API?
No public API is recorded for Quintian Pharma.
What industry is Quintian Pharma in?
Quintian Pharma's product category is Pharmaceutical Services. Its primary akta.pro industry code is HLAGAKAH, Pharmacovigilance Quality & Compliance (PV audits, QPPV support, PSMF). Its NAICS code is 54161 and its SIC code is 8742.